New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 20, 2014
10:08 EDTTAP, PAG, AN, UFS, ENTG, ESL, KMP, KR, MDTOn The Fly: Analyst Upgrade Summary
Today's noteworthy upgrades include: Autonation (AN) upgraded at Goldman... Domtar (UFS) upgraded to Neutral from Sell at Citigroup... Entegris (ENTG) upgraded to Overweight from Equal Weight at First Analysis... Esterline (ESL) upgraded at Canaccord... Kinder Morgan Energy (KMP) upgraded to Buy from Neutral at UBS... Kroger (KR) upgraded to Neutral from Sell at Goldman... Medtronic (MDT) upgraded to Buy from Hold at Jefferies... Molson Coors (TAP) upgraded at Morgan Stanley... Penske Automotive (PAG) upgraded to Neutral from Sell at Goldman.
News For AN;UFS;ENTG;ESL;KMP;KR;MDT;TAP;PAG From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
October 28, 2014
07:07 EDTENTGEntegris sees Q4 EPS 15c-21c, consensus 18c
Sees Q4 revenue $260M-$275M, consensus 269.29M.
07:06 EDTENTGEntegris reports Q3 EPS 21c, consensus 18c
Subscribe for More Information
October 27, 2014
15:36 EDTANNotable companies reporting before tomorrow's open
Subscribe for More Information
10:49 EDTKRKroger to hold investor conference
Subscribe for More Information
10:47 EDTKRKroger to hold an investor dinner meeting
Investor Dinner Meeting to be held in Cincinnati on October 28 at 8 pm. Webcast Link
October 24, 2014
10:03 EDTKMPOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
07:58 EDTTAPMolson Coors seen as winner if peers merge, Bloomberg says
Subscribe for More Information
07:50 EDTKMPKinder Morgan Energy downgraded to Hold from Buy at Argus
Subscribe for More Information
07:34 EDTKMPNEB prevents City of Burnaby from blocking Trans Mountain
Subscribe for More Information
October 23, 2014
11:25 EDTUFSDomtar rallies after MLP conversion discussion on call
Shares of Domtar rallied during the company's earnings conference call as the possibility of a master limited partnership conversation was addressed. Domtar stated that if it feels it would have "something compelling in the marketplace," it could consider the possibility of an MLP. It added, "If there's something there that could create shareholder value, you'll see us doing something or sharing something with the market." Shares of Domtar are up 9% to $39.44 in late morning trading. The call is now over.
07:34 EDTUFSDomtar sees Q4 paper shipments declining due to seasonality
Subscribe for More Information
07:33 EDTUFSDomtar reports Q3 adjusted EPS 94c, consensus 82c
Subscribe for More Information
October 22, 2014
07:21 EDTMDTU.S. DHS investigates medical gear for potential cyber defects, Reuters says
Subscribe for More Information
October 21, 2014
09:52 EDTMDTCovidien rises after Medtronic maintains merger date language
Shares of Covidien (COV) are rising in early trading after Medtronic (MDT), in its latest regulatory filing answering questions for shareholders regarding its proposed takeover of the Irish drugmaker, left its language regarding the expected closing date unchanged. WHAT'S NEW: In its most recent filing, Medtronic again stated, "As of the date of this joint proxy statement/prospectus, the transaction is expected to be completed late in the fourth calendar quarter of 2014 or early 2015. However, no assurance can be provided as to when or if the transaction will be completed. The required vote of Medtronic and Covidien shareholders to adopt the required shareholder proposals at their respective special meetings, as well as the necessary regulatory consents and approvals, must first be obtained and other conditions specified in the conditions appendix must be satisfied or, to the extent applicable, waived." ANALYST REACTION: Research firm BTIG says Medtronic's amended regulatory filing on the Covidien transaction increases the firm's confidence of the deal closing by early 2015. The firm adds it would be "stunned" to see Medtronic walk away from the merger after the company again showed commitment to the acquisition. WHAT'S NOTABLE: AbbVie (ABBV) last night confirmed that the company and Shire (SHPG), another Irish domiciled drugmaker, agreed to terminate their proposed merger. AbbVie said its decision was based upon its assessment of the September 22 notice issued by the U.S. Department of Treasury, which re-interpreted longstanding tax principles in a "uniquely selective manner designed specifically to destroy the financial benefits of these types of transactions." AbbVie continued that the Treasury notice "introduced an unacceptable level of risk and uncertainty given the magnitude of the proposed changes" and the stated intention of the department to continue to revise tax principles to further impact such "tax inversion" transactions. AbbVie noted that it has agreed to pay Shire a break fee of approximately $1.64B due to the deal falling through. PRICE ACTION: In early trading, shares of Covidien trading in New York rose 4% to $88.86, Medtronic advanced 1% to $64.57, Shires gained 0.7% to $185.82 and AbbVie added 1.4% to $55.16.
09:43 EDTMDTAmended filing increases confidence in Covidien deal at BTIG
BTIG says Medtronic's (MDT) amended regulatory filing on the Covidien (COV) transaction increases its confidence of the deal closing by early 2015. The firm adds it would be "stunned" to see Medtronic walk away from the merger after the company again showed commitment to the acquisition. Shares of Covidien are up 3% to $88.11 in early trading.
09:11 EDTMDTMedtronic keeps language unchanged on merger closing date
Medtronic in its latest regulatory filing answering questions for shareholders regarding its proposed takeover of Covidien (COV) left the language unchanged around the expected closing date. The company again stated, "As of the date of this joint proxy statement/prospectus, the transaction is expected to be completed late in the fourth calendar quarter of 2014 or early 2015. However, no assurance can be provided as to when or if the transaction will be completed. The required vote of Medtronic and Covidien shareholders to adopt the required shareholder proposals at their respective special meetings, as well as the necessary regulatory consents and approvals, must first be obtained and other conditions specified in the conditions appendix must be satisfied or, to the extent applicable, waived."
07:26 EDTKMPKinder Morgan pipeline faces opposition from native tribes, Reuters says
Kinder Morgan's plans for a Canadian pipeline expansion worth $4.8B is now up against lawsuits from indigenous communities who are aiming to use the courts to hinder the proposed oil pipeline, according to Reuters, citing comments from Grand Chief of the Union of British Columbia Indian Chiefs Stewart Phillip. Reference Link
October 20, 2014
07:20 EDTMDTInternational Continence Society to hold annual meeting
ICS Annual Meeting 2014 is being held in Rio de Janeiro, Brazil on October 20-24.
07:12 EDTMDTCongress of Neurological Surgeons to hold annual meeting
Subscribe for More Information
October 16, 2014
06:17 EDTMDTJefferies says Medtronic 'needs to do' Covidien takeover
Jefferies says it "can't see how Medtronic walks" from the Covidien (COV) takeover given how compelling the merger is. The firm confirmed with Medtronic (MDT) that nothing has changed in the company's commitment to the deal since new financing terms were announced on October 3. In Jefferies view, "Medtronic needs to do this deal." It notes the spread on the acquisition widened significantly on the news that Abbvie (ABBV) is reconsidering its acquisition of Shire (SHPG).
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use